Sector dividends VYNE Therapeutics Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-10 pm EST			5-day change	1st Jan Change
3.430 ^USD	-12.50%		-0.87%	+2.39%

Jan. 06	VYNE Therapeutics Completes Enrollment in Phase 2B Trial Evaluating Vyn201 for the Treatment of Nonsegmental Vitiligo	CI
Dec. 23	VYNE Therapeutics Reports 'Positive' Phase 1a Results for VYN202 Inhibitor	MT

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Yield (Y)	Yield (Y+1)	P/E ratio (Y)	Price to Book	EV / Sales	EV / EBITDA	EV / EBIT	Capi. ($)
VERTEX PHARMACEUTICALS INCORPORATED	-.--%	-.--%	-254.8x	6.456	8.85x	109.96x	142.51x	105B
REGENERON PHARMACEUTICALS, INC.	-.--%	-.--%	18.05x	2.538	4.63x	11.43x	12.44x	74.98B
ARGENX SE	-.--%	-.--%	1818.28x	9.262	18.05x	-630.73x	-508.87x	39.79B
BIONTECH SE	-.--%	-.--%	-38.01x	1.479	5.98x	-12.84x	-10.69x	29.45B
WUXI APPTEC CO., LTD.	+1.84%	+2.00%	16.35x	2.514	3.65x	10.37x	12.54x	20.86B
BEIGENE, LTD.	-.--%	-.--%	-32.47x	5.602	4.63x	-31.48x	-27.01x	18.83B
NEUROCRINE BIOSCIENCES, INC.	-.--%	-.--%	35.03x	5.094	5.32x	19.96x	20.32x	14.27B
GENMAB A/S	-.--%	-.--%	19.22x	3.055	4.01x	12.43x	13.26x	14B
SAREPTA THERAPEUTICS, INC.	-.--%	-.--%	52.2x	9.164	6.21x	49.95x	77.26x	11.92B
INSMED INCORPORATED	-.--%	-.--%	-12.19x	49.18	34.13x	-14.61x	-14.4x	11.67B
EXELIXIS, INC.	-.--%	-.--%	20.93x	4.345	4.29x	14.49x	15.88x	10.29B
VAXCYTE, INC.	-.--%	-.--%	-20.07x	-	-	-16.41x	-15.88x	10.11B
WUXI BIOLOGICS (CAYMAN) INC.	-.--%	-.--%	20.42x	1.493	3.39x	10.28x	13.81x	9.07B
ASCENDIS PHARMA A/S	-.--%	-.--%	-17.7x	-148.600400	26.21x	-26.38x	-22.56x	7.72B
MADRIGAL PHARMACEUTICALS, INC.	-.--%	-.--%	-14.36x	10.96	39.02x	-12.06x	-12.28x	7.39B
PHARMAESSENTIA CORPORATION	+0.36%	+0.44%	85.9x	8.818	23.15x	126.27x	124.75x	7.26B
ZEALAND PHARMA A/S	-.--%	-.--%	-57.17x	5.406	128.96x	-51.65x	-47.76x	7.12B
Average	+0.13%	+0.14%	96.45x	-1.45	20.03x	-25.35x	-13.34x	23.54B
Weighted average by Cap.	+0.10%	+0.11%	117.08x	3.42	11.78x	-30.43x	-7.97x